Detection and knockdown of MicroRNA-34a using thioacetamido nucleic acid

Nucleic Acid Therapeutics

Volumn 23, Issue 3, 2013, Pages 195-202

  Soni, Kartik ^a   Gupta, Shivani ^a   Gokhale, Sachin S ^b   Dey, Rakesh ^a   Gunjal, Anita D ^b   Kumar, Vaijayanti A ^b   Pillai, Beena ^a  

^a CSIR INSTITUTE OF GENOMICS AND INTEGRATIVE BIOLOGY   (India)

^b NATIONAL CHEMICAL LABORATORY   (India)

Author keywords

[No Author keywords available]

Indexed keywords

5 METHYLCYTIDYLCYTIDINE; ANTISENSE OLIGONUCLEOTIDE; CYTIDINE DERIVATIVE; LOCKED NUCLEIC ACID; MICRORNA 34A; NUCLEIC ACID; ONCOPROTEIN; THIOACETAMIDO NUCLEIC ACID; UNCLASSIFIED DRUG;

ARTICLE; CELL LEVEL; CONTROLLED STUDY; DNA SEQUENCE; GENE EXPRESSION; GENE SILENCING; HUMAN; HUMAN CELL; PRIORITY JOURNAL; RNA ANALYSIS; SYNTHESIS;

APOPTOSIS; CELL LINE, TUMOR; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE KNOCKDOWN TECHNIQUES; GENES, MYC; HEK293 CELLS; HUMANS; MICRORNAS; OLIGONUCLEOTIDES; THYMIDINE; TUMOR SUPPRESSOR PROTEIN P53;

EID: 84878222252     PISSN: 21593337     EISSN: None     Source Type: Journal    
DOI: 10.1089/nat.2012.0411     Document Type: Article

References (27)

1. Ahluwalia, J.K., Khan, S.Z., Soni, K., et al. (2008). Human cellular microRNA hsa-miR-29a interferes with viral Nef protein expression and HIV-1 replication. Retrovirology 5, 117.
2. Azimzadeh, J.S., and Masoudi-Nejad, A. (2011). RNAi pathway integration in Caenorhabditis elegans development. Funct. In-tegr. Genomics 11, 389-405.
3. Bartel, D.P. (2004). MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116, 281-297.
4. Eulalio, A., Huntzinger, E., Nishihara, T., Rehwinkel, J., Fauser, M., and Izaurralde, E. (2009). Deadenylation is a widespread effect of miRNA regulation. RNA 15, 21-32.
5. Feng, W., and Feng, Y. (2011). MicroRNAs in neural cell development and brain diseases. Sci. China Life Sci. 54, 1103-1112.
6. Fu, T., Choi, S.E., Kim, D.H., Seok, S., Suino-Powell, K.M., Xu, H.E., and Kemper, J.K. (2012). Aberrantly elevated microRNA-34a in obesity attenuates hepatic responses to FGF19 by targeting a membrane coreceptor beta-Klotho. Proc. Natl. Acad. Sci. U. S. A. 109, 16137-16142.
7. Garcia-Lopez, J. and Del, M.J. (2012). Expression dynamics of microRNA biogenesis during preimplantation mouse development. Biochim. Biophys. Acta 1819, 847-854.
8. Ghosh, T., Soni, K., Scaria, V., Halimani, M., Bhattacharjee, C., and Pillai, B. (2008). MicroRNA-mediated up-regulation of an alternatively polyadenylated variant of the mouse cytoplasmic {beta}-actin gene. Nucleic Acids Res. 36, 6318-6332.
9. Gogoi, K., Gunjal, A.D., Phalgune, U.D., and Kumar, V.A. (2007a). Synthesis and RNA binding selectivity of oligonu-cleotides modified with five-atom thioacetamido nucleic acid backbone structures. Org. Lett. 9, 2697-2700.
10. Gogoi, K., Mane, M.V., Kunte, S.S., and Kumar, V.A. (2007b). A versatile method for the preparation of conjugates of peptides with DNA/PNA/analog by employing chemo-selective click reaction in water. Nucleic Acids Res, 35, e139.
11. Gokhale, S.S., Gogoi, K. and Kumar, V.A. (2010). Probing binding preferences of DNA and RNA: backbone chirality of thioacetamido-linked nucleic acids and iso-thioacetamido-linked nucleic acids to differentiate DNA versus RNA selective binding. J. Org. Chem. 75, 7431-7434.
12. Hermeking, H. (2010). The miR-34 family in cancer and apo-ptosis. Cell Death Differ. 17, 193-199.
13. Kaur, H., Arora, A., Gogoi, K., Solanke, P., Gunjal, A.D., Kumar, V.A., and Maiti, S. (2009). Effects for the incorporation of five-atom thioacetamido nucleic acid (TANA) backbone on hybridization thermodynamics and kinetics of DNA duplexes. J. Phys. Chem. B 113, 2944-2951.
14. Kong, L., Zhu, J., Han, W., Chen, Q.R., Cheuk, A.T., Tsang, P., Zhang, Q., Thiele, C.J., Slack, A., Shohet, J., and Khan, J. (2011). Significance of serum microRNAs in pre-diabetes and newly diagnosed type 2 diabetes: a clinical study. Acta Dia-betol. 48, 61-69.
15. Li, C., Pei, F., Zhu, X., Duan, D.D., and Zeng, C. (2012). Circulating microRNAs as novel and sensitive biomarkers of acute myocardial Infarction. Clin. Biochem. 45, 727-732.
16. Li, N., Fu, H., Tie, Y., Hu, Z., Kong, W., Wu, Y., and Zheng, X. (2009). miR-34a inhibits migration and invasion by down-regulation of c-Met expression in human hepatocellular carcinoma cells. Cancer Lett. 275, 44-53.
17. Liu, J., Zheng, M., Tang, Y.L., Liang, X.H., and Yang, Q. (2011). MicroRNAs, an active and versatile group in cancers. Int. J. Oral Sci. 3, 165-175.
18. Livak, K.J., and Schmittgen, T.D. (2001). Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 25, 402-408.
19. Lujambio, A., and Lowe, S.W. (2012). The microcosmos of cancer. Nature 482, 347-355.
20. Pillai, R.S., Bhattacharyya, S.N., Artus, C.G., Zoller, T., Cougot, N., Basyuk, E., Bertrand, E., and Filipowicz, W. (2005). Inhibition of translational initiation by Let-7 MicroRNA in human cells. Science 309, 1573-1576.
21. Salta, E., and De, S.B. (2012). Non-coding RNAs with essential roles in neurodegenerative disorders. Lancet Neurol. 11, 189-200.
22. Stenvang, J., Petri, A., Lindow, M., Obad, S., and Kauppinen, S. (2012). Inhibition of microRNA function by antimiR oligonu-cleotides. Silence 3, 1.
23. van, R.E., Purcell, A.L., and Levin, A.A. (2012). Developing microRNA therapeutics. Circ. Res. 110, 496-507.
24. Wei, J.S., Song, Y.K., Durinck, S., et al. (2008). The MYCN oncogene is a direct target of miR-34a. Oncogene 27, 5204-5213.
25. Xu, J., Zhao, J., Evan, G., Xiao, C., Cheng, Y., and Xiao, J. (2011). Circulating microRNAs: novel biomarkers for cardiovascular diseases. J. Mol. Med. (Berl.) 90, 865-875.
26. Yeung, M.L., Bennasser, Y., Myers, T.G., Jiang, G., Benkirane, M., and Jeang, K.T. (2005). Changes in microRNA expression profiles in HIV-1-transfected human cells. Retrovirology 2, 81.
27. Zhao, Z., Zhao, Q., Warrick, J., Lockwood, C.M., Woodworth, A., Moley, K.H., and Gronowski, A.M. (2012). Circulating microRNA miR-323-3p as a biomarker of ectopic pregnancy. Clin. Chem. 58, 896-905.